Geroscience Pathology and Cellular Histology
Geroscience Pathology and Cellular Histology
批准号:
10561627
负责人:
YUJI IKENO
金额:
$24.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-06-01 至 2024-04-30
关键词:
AdipocytesAdipose tissueAffectAgeAgingAnimalsArchivesBiochemicalBiologicalBiostatistics CoreBrainCell AgingCellsCellular MorphologyControl AnimalDataData AnalysesDatabasesDevelopmentDiseaseElderlyExcisionFreezingFrozen SectionsFutureGeneticGeroscienceGliosisGlomerulonephritisHeartHistologicHistologyHistopathologyImageImmunohistochemistryIn Situ HybridizationInfiltrationInterventionInvestigationIslets of LangerhansLesionLiverMacrophageMeasuresMolecularMorbidity - disease rateMorphologyMusParaffinParaffin EmbeddingPathologicPathologyPhysiologicalPrevalenceRNARattusResearchResearch PersonnelResource DevelopmentResourcesSamplingServicesSeveritiesSkeletal MuscleSlideStainsTechniquesTestingTissue imagingTissuesTumor Burdenage relatedboneburden of illnesscellular targetingdigital imaginghealthspanhistological stainsinsightjuvenile animalmortalityneoplasticpharmacologicsenescencetissue archivetraittrend analysis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
CORE D: SUMMARY Ikeno
In order to determine the impact of an experimental intervention on aging, it is essential that investigators
understand how an intervention alters pathological lesions that occur with age. Pathology increases
exponentially with advancing age and is largely responsible for age-related morbidity and mortality. Pathological
information also provides investigators with insight into the potential biological/molecular mechanism(s) of the
intervention. Furthermore, pathological assessment of old animals is necessary to help investigators determine
whether changes in the physiological and biochemical parameters measured are associated with or are
independent of any underlying pathological conditions. In addition, pathological analysis of young animals
provides investigators with information about genetic and pharmacological interventions that affect
development. Thus, it is essential to obtain accurate and thorough pathological assessments of aging in both old
and young animals. The Geroscience Pathology and Cellular Histology Core (GPCHC) will provide Project
investigators with detailed pathological analyses of lesions that occur with age in the animals. The GPCHC will
also provide investigators with cellular senescence characterization, histopathological, morphometric, and
immunohistochemical analyses of specific lesions and tissues (e.g., neoplastic lesions, glomerulonephritis,
gliosis in the brain, number and size of pancreatic islets, macrophage infiltration, and fat cell morphology in
adipose tissue) obtained from the mice studied. In addition, the GPCHC will develop a comprehensive database
of histopathological data and images of histopathology slides as a resource for: 1) trend analyses by the
investigators; and 2) a tissue archive containing paraffin and frozen blocks for analysis of samples by request
and for new morphological research. Furthermore, the GPCHC will provide investigators with histological
support. We will prepare paraffin-embedded and frozen blocks, make unstained paraffin or frozen sections, and
perform various histological staining techniques, including special staining.
These data will allow investigators to evaluate the effects of genetic and pharmacological manipulations on the
development of potentially fatal lesions and age-sensitive traits, and also provide information on whether the
biochemical/molecular changes observed in the projects are correlated to the histopathological changes in
specific tissues.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Reduced thioredoxin in both the cytosol and mitochondria: a key modulator of age-related cancer development in Trx1KO x Trx2KO mice?
-
批准号:10097763
-
项目类别:
-
资助金额:$38.76万
-
财政年份:2021
-
负责人:YUJI IKENO
-
依托单位:
Reduced thioredoxin in both the cytosol and mitochondria: a key modulator of age-related cancer development in Trx1KO x Trx2KO mice?
-
批准号:10681359
-
项目类别:
-
资助金额:$42.59万
-
财政年份:2021
-
负责人:YUJI IKENO
-
依托单位:
Reduced thioredoxin in both the cytosol and mitochondria: a key modulator of age-related cancer development in Trx1KO x Trx2KO mice?
-
批准号:10477930
-
项目类别:
-
资助金额:$41.36万
-
财政年份:2021
-
负责人:YUJI IKENO
-
依托单位:
Geroscience Pathology and Cellular Histology
-
批准号:10349484
-
项目类别:
-
资助金额:$26.2万
-
财政年份:2019
-
负责人:YUJI IKENO
-
依托单位:
Anti-aging and anti-cancer effects of thioredoxins
-
批准号:8333000
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:YUJI IKENO
-
依托单位:
Anti-aging and anti-cancer effects of thioredoxins
-
批准号:8452588
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:YUJI IKENO
-
依托单位:
Anti-aging and anti-cancer effects of thioredoxins
-
批准号:8696808
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:YUJI IKENO
-
依托单位:
Pathology Core
-
批准号:8100949
-
项目类别:
-
资助金额:$13.16万
-
财政年份:2010
-
负责人:YUJI IKENO
-
依托单位:
PATHOLOGY CORE
-
批准号:6946253
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2005
-
负责人:YUJI IKENO
-
依托单位:
Pathology Core
-
批准号:10045451
-
项目类别:
-
资助金额:$16.27万
-
财政年份:1997
-
负责人:YUJI IKENO
-
依托单位:
Pathology Core
-
批准号:10438864
-
项目类别:
-
资助金额:$18.06万
-
财政年份:1997
-
负责人:YUJI IKENO
-
依托单位:
Pathology Core
-
批准号:10260626
-
项目类别:
-
资助金额:$16.19万
-
财政年份:1997
-
负责人:YUJI IKENO
-
依托单位:
Pathology Core
-
批准号:10652370
-
项目类别:
-
资助金额:$18.01万
-
财政年份:1997
-
负责人:YUJI IKENO
-
依托单位:
Pathology Core
-
批准号:8572521
-
项目类别:
-
资助金额:$13.85万
-
财政年份:1997
-
负责人:YUJI IKENO
-
依托单位:
Pathology Core
-
批准号:8572567
-
项目类别:
-
资助金额:$12.99万
-
财政年份:1997
-
负责人:YUJI IKENO
-
依托单位:
Pathology Core
-
批准号:8959555
-
项目类别:
-
资助金额:$11.42万
-
财政年份:--
-
负责人:YUJI IKENO
-
依托单位:
Pathology Core
-
批准号:9110201
-
项目类别:
-
资助金额:$11.46万
-
财政年份:--
-
负责人:YUJI IKENO
-
依托单位:
PATHOLOGY
-
批准号:8248257
-
项目类别:
-
资助金额:$19.4万
-
财政年份:--
-
负责人:YUJI IKENO
-
依托单位:
PATHOLOGY
-
批准号:8377757
-
项目类别:
-
资助金额:$21.3万
-
财政年份:--
-
负责人:YUJI IKENO
-
依托单位:
PATHOLOGY
-
批准号:8448202
-
项目类别:
-
资助金额:$19.44万
-
财政年份:--
-
负责人:YUJI IKENO
-
依托单位:
海外基金